Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 4966 AL 4980

Acute Presentation of Nonmotor Symptoms in Parkinson's Disease

Kwei K, Frucht S.

Int Rev Neurobiol. 2017;134:973-986. doi: 10.1016/bs.irn.2017.06.002. Epub 2017 Jul 10.

La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder

van Meerkerk-Aanen PJ, de Vroege L, Khasho D, Foruz A, van Asseldonk JT, van der Feltz-Cornelis CM.

Neuropsychiatr Dis Treat. 2017 Aug 2;13:2057-2067. doi: 10.2147/NDT.S130475. eCollection 2017.

Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease

Picillo M, Barone P, Pellecchia MT.

Mov Disord Clin Pract. 2017 Aug 21;4(5):652-662. doi: 10.1002/mdc3.12521. eCollection 2017 Sep-Oct.

Cognitive dysfunction and symptoms of movement disorders in adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

Ikeuchi T, Mezaki N, Miura T.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S39-S41. doi: 10.1016/j.parkreldis.2017.08.018. Epub 2017 Aug 16.

Cognitive complaint in early Parkinson's disease: A pilot study

Dupouy J, Ory-Magne F, Mekies C, Rousseau V, Puel M, Rerat K, Pariente J, Brefel-Courbon C; PARKMIP group.

Acta Neurol Scand. 2018 Jan;137(1):59-66. doi: 10.1111/ane.12808. Epub 2017 Aug 22.

Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)

Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ.

Mov Disord. 2017 Dec;32(12):1701-1709. doi: 10.1002/mds.27131. Epub 2017 Aug 21.

Blink rate is associated with drug-induced parkinsonism in patients with severe mental illness, but does not meet requirements to serve as a clinical test: the Curacao extrapyramidal syndromes study XIII

Mentzel CL, Bakker PR, van Os J, Drukker M, Matroos GE, Tijssen MAJ, van Harten PN.

J Negat Results Biomed. 2017 Aug 25;16(1):15. doi: 10.1186/s12952-017-0079-y.

Directional DBS increases side-effect thresholds-A prospective, double-blind trial

Dembek TA, Reker P, Visser-Vandewalle V, Wirths J, Treuer H, Klehr M, Roediger J, Dafsari HS, Barbe MT, Timmermann L.

Mov Disord. 2017 Oct;32(10):1380-1388. doi: 10.1002/mds.27093. Epub 2017 Aug 26.

How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology

Borghammer P.

Mov Disord. 2018 Jan;33(1):48-57. doi: 10.1002/mds.27138. Epub 2017 Aug 26.

Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study

Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K; Kanto NMPD investigators.

J Neurol Neurosurg Psychiatry. 2017 Nov;88(11):953-959. doi: 10.1136/jnnp-2017-316136. Epub 2017 Aug 28.

Clinical utility and research frontiers of neuroimaging in movement disorders

Nobili F, Westman E, Kogan RV, Pereira JB, Massa F, Grazzini M, Meles SK, Leenders KL.

Q J Nucl Med Mol Imaging. 2017 Dec;61(4):372-385. doi: 10.23736/S1824-4785.17.03018-7. Epub 2017 Aug 28.

Treatment gaps in Parkinson's disease care in the Philippines

Jamora RDG, Miyasaki JM.

Neurodegener Dis Manag. 2017 Aug;7(4):245-251. doi: 10.2217/nmt-2017-0014. Epub 2017 Aug 30.

Cannabinoids in Parkinson's Disease

Stampanoni Bassi M, Sancesario A, Morace R, Centonze D, Iezzi E.

Cannabis Cannabinoid Res. 2017 Feb 1;2(1):21-29. doi: 10.1089/can.2017.0002. eCollection 2017.

Levodopa treatment and dendritic spine pathology

Nishijima H, Ueno T, Funamizu Y, Ueno S, Tomiyama M.

Mov Disord. 2018 Jul;33(6):877-888. doi: 10.1002/mds.27172. Epub 2017 Sep 7.

Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis

Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, Calabresi P, Parnetti L.

Mov Disord. 2017 Oct;32(10):1389-1400. doi: 10.1002/mds.27110. Epub 2017 Sep 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias